These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15119289)

  • 1. Micronutrient supplementation shows promise in placebo-controlled trial.
    James JS
    AIDS Treat News; 2004 Feb; (398):4-5. PubMed ID: 15119289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial.
    Kaiser JD; Campa AM; Ondercin JP; Leoung GS; Pless RF; Baum MK
    J Acquir Immune Defic Syndr; 2006 Aug; 42(5):523-8. PubMed ID: 16868496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications & side effects. Supplements and CD4+ counts: study finds surprising results.
    TreatmentUpdate; 2004 Mar; 16(2):4-6. PubMed ID: 17219668
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to "Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial".
    Smith DM
    J Acquir Immune Defic Syndr; 2007 May; 45(1):128; author reply 128-9; discussion 129. PubMed ID: 17460480
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple micronutrient supplementation does not reduce diarrhoea morbidity in Ugandan HIV-infected children: a randomised controlled trial.
    Ndeezi G; Tylleskar T; Ndugwa CM; Tumwine JK
    Paediatr Int Child Health; 2012 Feb; 32(1):14-21. PubMed ID: 22525443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary supplement use and nutrient intake in HIV-infected persons.
    Hendricks KM; Sansavero M; Houser RF; Tang AM; Wanke CA
    AIDS Read; 2007 Apr; 17(4):211-6, 223-7. PubMed ID: 17479507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection.
    Singhal N; Fergusson D; Huff H; Mills EJ; la Porte C; Walmsley S; Cameron DW
    Contemp Clin Trials; 2010 Nov; 31(6):604-11. PubMed ID: 20708714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada.
    Hemsworth JC; Hekmat S; Reid G
    Gut Microbes; 2012; 3(5):414-9. PubMed ID: 22825497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antioxidants on CD4 and viral load in HIV-infected women in sub-Saharan Africa - dietary supplements vs. local diet.
    Nkengfack GN; Torimiro JN; Englert H
    Int J Vitam Nutr Res; 2012 Feb; 82(1):63-72. PubMed ID: 22811378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term folinic acid supplementation improves vascular reactivity in HIV-infected individuals: a randomized trial.
    Grigoletti SS; Guindani G; Moraes RS; Ribeiro JP; Sprinz E
    Nutrition; 2013 Jun; 29(6):886-91. PubMed ID: 23660169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of multivitamin supplements and HIV disease progression and mortality.
    Fawzi WW; Msamanga GI; Spiegelman D; Wei R; Kapiga S; Villamor E; Mwakagile D; Mugusi F; Hertzmark E; Essex M; Hunter DJ
    N Engl J Med; 2004 Jul; 351(1):23-32. PubMed ID: 15229304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting JNK to prevent antiretroviral neuropathy.
    Galeotti N
    Oncotarget; 2017 Feb; 8(8):12546-12547. PubMed ID: 28179580
    [No Abstract]   [Full Text] [Related]  

  • 13. Side effects and complications. Can statins help reverse body-shape changes in men?
    TreatmentUpdate; 2005 Dec; 17(7):11-2. PubMed ID: 17228404
    [No Abstract]   [Full Text] [Related]  

  • 14. How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4+ cell count responses to antiretroviral therapy?
    Phillips P
    Clin Infect Dis; 2005 May; 40(9):1379-80; author reply 1380-1. PubMed ID: 15825049
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.
    Kallianpur AR; Hulgan T; Canter JA; Ritchie MD; Haines JL; Robbins GK; Shafer RW; Clifford DB; Haas DW
    AIDS; 2006 Jul; 20(11):1503-13. PubMed ID: 16847405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis of latent tuberculosis in HIV-infected persons.
    Boyd AE; Bothamley GH
    Clin Infect Dis; 2006 May; 42(10):1498; author reply 1499-500. PubMed ID: 16619166
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of CD4 count, viral load and highly active antiretroviral therapy in HIV-associated thrombotic thrombocytopenic purpura (TTP).
    Hill QA; Minton J
    Sex Transm Infect; 2012 Feb; 88(1):38-9. PubMed ID: 22045846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term consequences of antiretroviral therapy.
    Smith D
    J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved appetite after multi-micronutrient supplementation for six months in HIV-infected South African children.
    Mda S; van Raaij JM; Macintyre UE; de Villiers FP; Kok FJ
    Appetite; 2010 Feb; 54(1):150-5. PubMed ID: 19815042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.